
Remimazolam Sedation
Dr David Green was the first clinician in the United Kingdom to introduce remimazolam into clinical practice. Since 2021, he has developed one of the UK's largest real-world remimazolam practices, encompassing more than 1,000 cases across fertility, cardiology and surgical settings. Remimazolam offers rapid onset, predictable pharmacology, haemodynamic stability and improved patient throughput — and Green Anaesthetic Limited provides practical expertise in both consultant-delivered and protocol-driven remimazolam sedation pathways.
Consultant-Led Sedation
Direct consultant anaesthetic support for procedural sedation across a range of clinical settings. Every service is supported by:
Nurse-Led Sedation Programme Design
Where full consultant presence is not required, we develop and oversee nurse-led sedation models with:
These systems have been successfully implemented across both clinic and hospital environments.
Every sedation service delivered or designed by Green Anaesthetic Limited operates within a defined clinical governance framework, including: